Vaccines:

Indications for: HAVRIX

Hepatitis A immunization.

Adult Dosage:

Inject into deltoid, preferably at least 2 weeks before expected exposure. >18yrs: 1440 EL.U. once IM; give booster dose 6–12 months after initial course.

Children Dosage:

Inject IM preferably at least 2 weeks before expected exposure. <12months: not recommended. 12months–18yrs: 720 EL.U. once IM; give booster dose 6–12months after initial course.

HAVRIX Contraindications:

Neomycin allergy. Previous hypersensitivity reaction to hepatitis A-containing vaccine.

HAVRIX Warnings/Precautions:

Have epinephrine (1:1000) inj available. Fever. Bleeding disorders. Immunodeficiency (may have suboptimal response). If given with immune globulin, use separate syringe and different site. Latex allergy. Pregnancy (Cat.C). Nursing mothers.

HAVRIX Interactions:

Immunosuppressives may reduce efficacy. Concomitant vaccines: see literature.

Adverse Reactions:

Inj site reactions, headache, fatigue, fever, malaise, anorexia, GI upset.

How Supplied:

Single-dose vials—10; Single-dose prefilled Tip-Lok syringes—5 (without needles)